The PennZone

  • Home
  • Non-profit
  • Books
  • Entertainment
  • Music
  • Marketing
  • Legal
  • Health
  • Artificial Intelligence

Waypoint Orthopedics Today Announced the Appointment of Jeffrey F. O'Donnell, Jr. as President
The PennZone/10119030

Trending...
  • Nutriband Inc. (N A S D A Q: NTRB) Breaks Into Uncharted Territory: 52-Week High Eclipsed as Shares Surge 22% —AVERSA™ Puts Investors on High Alert
  • Growth Story Expands: $54.6M Contract, $30M Revenue Run Rate, 800+ Customers, 50+ Patents & New AI Cybersecurity Products for Cycurion, Inc $CYCU
  • Dr. Jay Johannigman Returns to Cincinnati Following 46 Years of Military Service
PHILADELPHIA, April 6, 2021 /PRNewswire/ -- Waypoint Orthopedics, Inc. today announced that its Board of Directors appointed Jeffrey F. O'Donnell, Jr. as President effective April 2, 2021.

Mr. O'Donnell joined Waypoint in January of 2021, serving as VP of Business Development and Marketing. In that role, Mr. O'Donnell has led the Company's early product development, regulatory, and business development efforts.

Chief Medical Officer and Co-Founder of Waypoint, Dr. Stephen P. Banco, M.D., said, "The Waypoint Orthopedics Board believes Jeff is the obvious choice, and we are thrilled to have him as our President. Jeff has been the driving force behind the company's operations and has essentially been functioning as the President since joining the company in January. We are confident that Jeff's insight and enthusiasm will be instrumental in bringing our product to fruition."

"I am honored and excited for the opportunity to continue to lead Waypoint with Dr. Banco and our extremely talented team. Waypoint's mission is to make vertebral fixation safer for the patient, the physician, the rep, and operating room personnel," said O'Donnell.

Prior to Waypoint, Mr. O'Donnell has been a healthcare entrepreneur operating in the emerging growth space within orthopedics, digital health, and cardiology. Earlier in his career, Mr. O'Donnell spent six years with Trice Medical in several different leadership roles. He started his healthcare career with MedImmune, Inc. He holds a B.A. from Saint Joseph's University.

More on The PennZone
  • Bicentennial Occult Outing Alternative History Video Series Launches for Spooky Season
  • Harvard Educated Board Certified Endodontist Joins Pearlfection Dentistry
  • NYC Banners Delivers High-Stakes UN General Assembly Backdrop for the US Department of State Event
  • OneVizion Appoints Energy Infrastructure Executive Walt Farrell to Board of Directors
  • Tampa Bay Reporter Launches with a Mission to Deliver Local News with National Reach

About Waypoint Orthopedics:

Waypoint Orthopedics, Inc. was founded in 2020 to make vertebral fixation safer and more efficient for the patient, surgeon, and support staff. Waypoint Orthopedics' controlling stockholder is Runway Healthcare, LP - a MedTech accelerator fund.

Forward-Looking Statements

This press release contains "forward-looking statements" concerning the development of Waypoint Orthopedics products, the potential benefits and attributes of those products, and the company's expectations regarding its prospects. Forward-looking statements are subject to risks, assumptions and uncertainties that could cause actual future events or results to differ materially from such statements. These statements are made as of the date of this press release. Actual results may vary.  Waypoint Orthopedics undertakes no obligation to update any forward-looking statements for any reason.

Inquires: [email protected]

Related Images

jeffrey-f-odonnell-jr.png
Jeffrey F. O'Donnell, Jr.
Jeffrey F. O'Donnell, Jr. - President, Waypoint Orthopedics.

SOURCE Waypoint Orthopedics
Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Pregis to Highlight EPR Expertise, Sustainable Packaging Solutions and Live Automation Demonstrations at Pack Expo International 2026
  • Infinity Infusion Solutions Launches "Women Leading Infusion Care" Campaign for National Women in Business Month
  • HuskyTail Digital Puts AI to Work Behind the Scenes to Cut Client Turnaround Time
  • AI, Real-World Data "RWD" and U.S. Expansion Put Predictive Healthcare in Focus for POMDOCTOR Ltd. (N A S D A Q: POM)
  • $11.18 Million DARPA Award Ignites a Major New Catalyst as FDA, Robotic TMS and Commercialization Milestones Converge for NRx Pharmaceuticals, Inc
  • Dave's Auto Services Launches Free Seven-Week Fall Maintenance Series for Boyertown-Area Drivers
  • P-Wave Classics to publish Thomas Holcroft's The Adventures of Hugh Trevor in three volumes, beginning 19 January
  • Ad Leverage Sponsors ServiceTitan Pantheon 2026, Supporting Education and Growth in the Home Services Industry
  • From Newcomers to Neighbors: LINC Celebrates the People Who Make the Valley Home
  • Lehigh Valley's Kellyn Featured in National Film Series Exploring the Future of Diabetes Care
  • Top 100 Golf Coach Daniel Guest and Imagen Golf Announce Partnership with Remo Golf at Fairways Golf Club
  • DBF Viewer 2000 v9.32 Adds New Control for Data Export
  • Badanamu Partners With Moonbug Entertainment In Landmark Distribution Deal
  • Exonerated Movers Launches in Philadelphia on International Wrongful Conviction Day
  • Atlas Advisors President and Founder Mike McGuire Named a 2026 Leader in Business and Finance by LVB
  • Client 1st Financial Founder Michael Fischer Recognized for Building a Relationship-Rooted Career
  • Nutriband (N A S D A Q: NTRB): Fighting Back Against the Fentanyl Crisis With a New Approach to Safer Transdermal Medicines
  • Curtis Salgado shares a love letter to the city of Chicago and Otis Rush with new single
  • Oral statement on the situation of Chairman Lee Man-hee in pretrial detention in the Republic of Korea
  • Names Are Not Important Asks What Remains When Identity Is Stripped of Labels

Popular on PennZone

  • Benny Turner Revisits Freddie King's Legacy for 50th Anniversary of His Passing - 250
  • Church Tradition Takes an Unexpected Turn at the Ford Community & Performing Arts Center - 217
  • GitKraken Names Jim Shaw CEO as Software Teams Move From AI Adoption to Multi-Agent Orchestration - 173
  • Brévant Guide Launches New National Restaurant Guide Across Canada - 140
  • VC Fast Pitch and Steamwork Ventures Bring Startup & Investor Networking Event to Santa Barbara on October 8 - 125
  • SHI Introduces the RP-222B3S, Its Highest-Capacity 4K Pulse Tube Cryocooler
  • FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
  • Sea Tales Strengthens U.S. Leadership Team as Retail Expansion Accelerates
  • Robert DeMaio, Phinge CEO to Speak at 30th IIPLA 2026 on Securing IP, User Data & Digital Sovereignty via Verified App-less Tech. Attend the Live Q&A!
  • Lake Norman Philharmonic - Free Community Concert

Similar on PennZone

  • NIL Club Data Shows Brands Are Looking Beyond Follower Counts in College Sports
  • NYC Banners Delivers High-Stakes UN General Assembly Backdrop for the US Department of State Event
  • Genuine Hospitality, LLC Selected to Operate Fairfield Inn & Suites Tampa Wesley Chapel
  • Pregis to Highlight EPR Expertise, Sustainable Packaging Solutions and Live Automation Demonstrations at Pack Expo International 2026
  • Infinity Infusion Solutions Launches "Women Leading Infusion Care" Campaign for National Women in Business Month
  • HuskyTail Digital Puts AI to Work Behind the Scenes to Cut Client Turnaround Time
  • AI, Real-World Data "RWD" and U.S. Expansion Put Predictive Healthcare in Focus for POMDOCTOR Ltd. (N A S D A Q: POM)
  • $11.18 Million DARPA Award Ignites a Major New Catalyst as FDA, Robotic TMS and Commercialization Milestones Converge for NRx Pharmaceuticals, Inc
  • Nutriband (N A S D A Q: NTRB): Fighting Back Against the Fentanyl Crisis With a New Approach to Safer Transdermal Medicines
  • Most Utah Deaths Never Reach the Medical Examiner. Postmortem Pathology Offers Salt Lake City a Private Autopsy Option
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us